ClinicalTrials.govpublic full text
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
solid tumors and hematologic malignancy, solid tumor, lymphoma, bet bromodomain inhibitor, brd, diffuse large b-cell lymphoma (dlbcl), burkitt's lymphoma, c-myc, colorectal cancer, non-small cell lung cancer, pancreatic adenocarcinoma, castration-resistant prostate cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 807660
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.